Sandra Mazzoni

Featured in: Favicon

nature.com Favicon

healio.com Favicon

cancernetwork.com Favicon

Articles

Dr Mazzoni on the Use of Quadruplet Regimens in Newly Diagnosed Myeloma

Oct 23, 2024 | onclive.com | Sandra Mazzoni

Sandra Mazzoni, DO, hematologist, medical oncologist, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the evolving treatment strategies for patients with newly diagnosed, transplant-eligible multiple myeloma, including the role for of quadruplet regimens in the frontline setting.
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

Apr 5, 2023 | mdpi.com | Danai Dima |Fauzia Ullah |Sandra Mazzoni |Louis Williams

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone | Bone Marrow Transplantation

Feb 24, 2023 | nature.com | Anne Hubben |Danai Dima |Sandra Mazzoni |Faiz Anwer

Author notesThese authors jointly supervised this work: Anne Hubben, Danai Dima.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →